NHG FINLAND OY

Their core work

NHG Finland is a Finnish health analytics and consulting SME specializing in data-driven decision support for elderly care and healthcare systems. They develop algorithms and machine learning tools to improve clinical outcomes — from predicting breast cancer adaptation to optimizing medication and treatment plans for older persons with complex chronic conditions. Their work bridges health informatics and real-world care delivery in home care and nursing home settings, with additional expertise in pandemic preparedness and health system resilience.

What they specialise in

How they've shifted over time

NHG Finland's early H2020 involvement (2015-2017) centered on active and healthy ageing policy support (PROEIPAHA) and predictive health analytics for cancer care (BOUNCE). From 2020 onward, their focus shifted sharply toward pandemic response systems and AI-driven individualized care for elderly populations with complex conditions. The trajectory shows a clear move from broad health policy coordination toward applied machine learning in geriatric care — a more specialized and technically deeper position.

NHG Finland is deepening its focus on machine learning for personalized elderly care, positioning itself as a go-to analytics partner for geriatric health innovation projects.

How they like to work

NHG Finland operates exclusively as a consortium participant, never coordinating — a pattern typical of specialized SMEs that contribute domain expertise rather than manage large projects. With 44 unique partners across just 4 projects, they consistently join large, multi-country consortia (averaging 11+ partners per project). This makes them an experienced and well-connected team player comfortable working within complex international collaborations.

Despite only four projects, NHG Finland has built a network spanning 44 partners across 16 countries — a remarkably broad reach indicating they are trusted contributors in large European health consortia. Their geographic connections are pan-European with no single dominant partner country beyond Finland.

What sets them apart

NHG Finland combines deep Finnish healthcare system knowledge with applied machine learning capabilities specifically tuned to elderly care — a niche where few SMEs operate at the EU project level. Their dual experience in both clinical decision support (medications, prognosis, treatment optimization) and health system resilience (pandemic response, supply chains) makes them a versatile partner. For consortium builders seeking a health analytics SME with real-world care delivery connections, NHG fills a gap between pure tech companies and clinical institutions.

Highlights from their portfolio

• I-CARE4OLD
  Their largest funded project (EUR 529K), combining geriatrics, big data, and ML for individualized elderly care — represents their core strategic direction.
• BOUNCE
  Largest single EC contribution (EUR 747K), applying predictive analytics to breast cancer patient adaptation — demonstrates their ML capabilities beyond geriatrics.
• HERoS
  Pandemic-era project addressing disinformation and supply chain disruption in health emergencies — shows adaptability to urgent societal challenges.